Lifelong pulmonary sequelae of bronchopulmonary dysplasia.


Journal

Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 23 2 2020
medline: 26 8 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

To summarize the current literature evaluating long-term pulmonary morbidity among surviving very preterm infants with bronchopulmonary dysplasia (BPD). BPD predisposes very preterm infants to adverse respiratory signs and symptoms, greater respiratory medication use, and more frequent need for rehospitalization throughout early childhood. Reassuringly, studies also indicate that older children and adolescents with BPD experience, on average, similar functional status and quality of life when compared to former very preterm infants without BPD. However, measured deficits in pulmonary function may persist in those with BPD and indicate an increased susceptibility to early-onset chronic obstructive pulmonary disease during adulthood. Moreover, subtle differences in exercise tolerance and activity may put survivors with BPD at further risk of future morbidity in later life. Despite advances in neonatal respiratory care, a diagnosis of BPD continues to be associated with significant pulmonary morbidity over the first two decades of life. Long-term longitudinal studies are needed to determine if recent survivors of BPD will also be at increased risk of debilitating pulmonary disease in adulthood.

Identifiants

pubmed: 32084032
doi: 10.1097/MOP.0000000000000884
pii: 00008480-202004000-00008
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-260

Références

Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276:357–368.
Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006; 367:1421–1431.
Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979; 95:819–823.
Tooley WH. Epidemiology of bronchopulmonary dysplasia. J Pediatr 1979; 95:851–855.
Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82:527–532.
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723–1729.
Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr 2018; 197:300–308.
Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants an evidence-based approach. Am J Respir Crit Care Med 2019; 200:751–759.
Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 2015; 314:1039–1051.
Lui K, Lee SK, Kusuda S, et al. Trends in outcomes for neonates born very preterm and very low birth weight in 11 high-income countries. J Pediatr 2019; 215:32–40.e14.
Janvier A, Farlow B, Baardsnes J, et al. Measuring and communicating meaningful outcomes in neonatology: a family perspective. Semin Perinatol 2016; 40:571–577.
Stevens TP, Finer NN, Carlo WA, et al. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr 2014; 165:240–249.
Pramana IA, Latzin P, Schlapbach LJ, et al. Respiratory symptoms in preterm infants: burden of disease in the first year of life. Eur J Med Res 2011; 16:223–230.
Skromme K, Leversen KT, Eide GE, et al. Respiratory illness contributed significantly to morbidity in children born extremely premature or with extremely low birthweights in 1999–2000. Acta Paediatr Int J Paediatr 2015; 104:1189–1198.
Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010; 182:237–245.
Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr 2014; 164:40–45.
Joshi S, Powell T, Watkins WJ, et al. Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. J Pediatr 2013; 162:813–818.
Ortiz LE, McGrath-Morrow SA, Sterni LM, Collaco JM. Sleep disordered breathing in bronchopulmonary dysplasia. Pediatr Pulmonol 2017; 52:1583–1591.
Garg M, Kurzner SI, Bautista DB, Keens TG. Clinically unsuspected hypoxia during sleep and feeding in infants with bronchopulmonary dysplasia. Pediatrics 1988; 81:635–642.
Broström EB, Thunqvist P, Adenfelt G, et al. Obstructive lung disease in children with mild to severe BPD. Respir Med 2010; 104:362–370.
Fortuna M, Carraro S, Temporin E, et al. Mid-childhood lung function in a cohort of children with ‘new bronchopulmonary dysplasia’. Pediatr Pulmonol 2016; 51:1057–1064.
Skromme K, Vollsæter M, Øymar K, et al. Respiratory morbidity through the first decade of life in a national cohort of children born extremely preterm. BMC Pediatr 2018; 18:102.
Beaudoin S, Tremblay GM, Croitoru D, et al. Healthcare utilization and health-related quality of life of adult survivors of preterm birth complicated by bronchopulmonary dysplasia. Acta Paediatr Int J Paediatr 2013; 102:607–612.
Caskey S, Gough A, Rowan S, et al. Structural and functional lung impairment in adult survivors of bronchopulmonary dysplasia. Ann Am Thorac Soc 2016; 13:1262–1270.
Smith VC, Zupancic JAF, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr 2004; 144:799–803.
Greenough A, Alexander J, Burgess S, et al. Healthcare utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004; 89:673–678.
Drysdale SB, Wilson T, Alcazar M, et al. Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax 2011; 66:468–473.
Hong T, Bolisetty S, Bajuk B, et al. A population study of respiratory rehospitalisation in very preterm infants in the first 3 years of life. J Paediatr Child Health 2016; 52:715–721.
Kuint J, Lerner-Geva L, Chodick G, et al. Rehospitalization through childhood and adolescence: association with neonatal morbidities in infants of very low birth weight. J Pediatr 2017; 188:135–141.e2.
Gough A, Spence D, Linden M, et al. General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: A systematic review. Chest 2012; 141:1554–1567.
Ryan RM, Keller RL, Poindexter BB, et al. Respiratory medications in infants <29 weeks during the first year postdischarge: the prematurity and respiratory outcomes program (PROP) consortium. J Pediatr 2019; 208:148–155.e3.
Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116:1353–1360.
Ioana Cristea A, Carroll AE, Davis SD, et al. Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home. Pediatrics 2013; 132:727.
Russell RB, Green NS, Steiner CA, et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007; 120:e1–e7.
Landry JS, Croitoru D, Jin Y, et al. Healthcare utilization by preterm infants with respiratory complications in Quebec. Can Respir J 2012; 19:255–260.
Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of healthcare. Science 1998; 282:245–246.
Gray PH, O’Callaghan MJ, Poulsen L. Behaviour and quality of life at school age of children who had bronchopulmonary dysplasia. Early Hum Dev 2008; 84:1–8.
Ronkainen E, Kaukola T, Marttila R, et al. School-age children enjoyed good respiratory health and fewer allergies despite having lung disease after preterm birth. Acta Paediatr Int J Paediatr 2016; 105:1298–1304.
Bozzetto S, Carraro S, Tomasi L, et al. Health-related quality of life in adolescent survivors of bronchopulmonary dysplasia. Respirology 2016; 21:1113–1117.
Brady JM, Zhang H, Kirpalani H, DeMauro SB. Living with severe bronchopulmonary dysplasia—parental views of their child's quality of life. J Pediatr 2019; 207:117–122.
Sriram S, Schreiber MD, Msall ME, et al. Cognitive development and quality of life associated with BPD in 10-year-olds born preterm. Pediatrics 2018; 141: e20172719.
Meijer-Schaap L, Dubois AEJ, Kollen BJ, et al. Development and construct validation of a parent-proxy quality of life instrument in children with bronchopulmonary dysplasia aged 4-8 years old. Qual Life Res 2019; 28:523–533.
Landry JS, Tremblay GM, Li PZ, et al. Lung function and bronchial hyperresponsiveness in adults born prematurely: a cohort study. Ann Am Thorac Soc 2016; 13:17–24.
Um-Bergström P, Hallberg J, Pourbazargan M, et al. Pulmonary outcomes in adults with a history of bronchopulmonary dysplasia differ from patients with asthma. Respir Res 2019; 20:102.
Gough A, Linden M, Spence D, et al. Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. Eur Respir J 2014; 43:808–816.
Islam JY, Keller RL, Aschner JL, et al. Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med 2015; 192:134–156.
Kotecha SJ, Edwards MO, Watkins WJ, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 2013; 68:760–761.
May C, Kennedy C, Milner AD, et al. Lung function abnormalities in infants developing bronchopulmonary dysplasia. Arch Dis Child 2011; 96:1014–1019.
Thunqvist P, Gustafsson P, Norman M, et al. Lung function at 6 and 18 months after preterm birth in relation to severity of bronchopulmonary dysplasia. Pediatr Pulmonol 2015; 50:978–986.
Doyle LW, Andersson S, Bush A, et al. Expiratory airflow in late adolescence and early adulthood in individuals born very preterm or with very low birthweight compared with controls born at term or with normal birthweight: a meta-analysis of individual participant data. Lancet Respir Med 2019; 7:677–686.
Um-Bergström P, Hallberg J, Thunqvist P, et al. Lung function development after preterm birth in relation to severity of bronchopulmonary dysplasia. BMC Pulm Med 2017; 17:97.
Yang J, Kingsford RA, Horwood J, et al. Lung function of adults born at very low birth weight. Pediatrics 2020; 145:e20192359.
Vollstæer M, Røksund OD, Eide GE, et al. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 2013; 68:767–776.
Proietti E, Riedel T, Fuchs O, et al. Can infant lung function predict respiratory morbidity during the first year of life in preterm infants? Eur Respir J 2014; 43:1642–1651.
Martinez FD. Early-life origins of chronic obstructive pulmonary disease. N Engl J Med 2016; 375:871–878.
Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1:1645–1648.
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357:1946–1955.
Simpson SJ, Turkovic L, Wilson AC, et al. Lung function trajectories throughout childhood in survivors of very preterm birth: a longitudinal cohort study. Lancet Child Adolesc Heal 2018; 2:350–359.
Doyle LW, Adams AM, Robertson C, et al. Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era. Thorax 2017; 72:712–719.
Doyle LW, Olinsky A, Faber B, Callanan C. Adverse effects of smoking on respiratory function in young adults born weighing less than 1000 grams. Pediatrics 2003; 112:565–569.
Ruf K, Thomas W, Brunner M, et al. Diverging effects of premature birth and bronchopulmonary dysplasia on exercise capacity and physical activity - a case control study. Respir Res 2019; 20:260.
Tsopanoglou SP, Davidson J, Goulart AL, et al. Functional capacity during exercise in very-low-birth-weight premature children. Pediatr Pulmonol 2014; 49:91–98.
Maclean JE, Dehaan K, Fuhr D, et al. Altered breathing mechanics and ventilatory response during exercise in children born extremely preterm. Thorax 2016; 71:1012–1019.
Vardar-Yagli N, Inal-Ince D, Saglam M, et al. Pulmonary and extrapulmonary features in bronchopulmonary dysplasia: a comparison with healthy children. J Phys Ther Sci 2015; 27:1761–1765.
Kriemler S, Keller H, Saigal S, Bar-Or O. Aerobic and lung performance in premature children with and without chronic lung disease of prematurity. Clin J Sport Med 2005; 15:349–355.
O’Dea CA, Logie K, Maiorana A, et al. Increased prevalence of expiratory flow limitation during exercise in children with bronchopulmonary dysplasia. ERJ Open Res 2018; 4:00048–02018.
Praprotnik M, Štucin Gantar I, Lučovnik M, et al. Respiratory morbidity, lung function and fitness assessment after bronchopulmonary dysplasia. J Perinatol 2015; 35:1037–1042.
Welsh L, Kirkby J, Lum S, et al. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax 2010; 65:165–171.
Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for elbw survivors in preadolescence: effect of neonatal chronic lung disease. J Pediatr 2003; 143:488–493.
Lovering AT, Elliott JE, Laurie SS, et al. Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity. Ann Am Thorac Soc 2014; 11:1528–1537.
Clemm HH, Vollsæter M, Røksund OD, et al. Exercise capacity after extremely preterm birth: development from adolescence to adulthood. Ann Am Thorac Soc 2014; 11:537–545.
DeMauro SB. The impact of bronchopulmonary dysplasia on childhood outcomes. Clin Perinatol 2018; 45:439–452.
Lowe J, Cousins M, Kotecha SJ, Kotecha S. Physical activity outcomes following preterm birth. Paediatr Respir Rev 2017; 22:76–82.
Spiegler J, Mendonca M, Wolke D. Prospective study of physical activity of preterm born children from age 5 to 14 years. J Pediatr 2019; 208:66–73.e7.
Saigal S, Stoskopf B, Pinelli J, et al. Self-perceived health-related quality of life of former extremely low birth weight infants at young adulthood. Pediatrics 2006; 118:1140–1148.
Kaseva N, Wehkalampi K, Strang-Karlsson S, et al. Lower conditioning leisure-time physical activity in young adults born preterm at very low birth weight. PLoS One 2012; 7:e32430.
Roberts G, Burnett AC, Lee KJ, et al. Quality of life at age 18 years after extremely preterm birth in the postsurfactant era. J Pediatr 2013; 163:1008–1013.
Tikanmäki M, Kaseva N, Tammelin T, et al. Leisure time physical activity in young adults born preterm. J Pediatr 2017; 189:135–142.e2.
Kajantie E, Strang-Karlsson S, Hovi P, et al. Adults born at very low birth weight exercise less than their peers born at term. J Pediatr 2010; 157:610–616.
Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:19–38.
McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; CD003793.
Jung A, Heinrichs I, Geidel C, Lauener R. Inpatient paediatric rehabilitation in chronic respiratory disorders. Paediatr Respir Rev 2012; 13:123–129.
Morales Mestre N, Papaleo A, Morales Hidalgo V, et al. Physical activity program improves functional exercise capacity and flexibility in extremely preterm children with bronchopulmonary dysplasia aged 4-6 years: a randomized controlled trial. Arch Bronconeumol 2018; 54:607–613.
Gibson AM, Doyle LW. Respiratory outcomes for the tiniest or most immature infants. Semin Fetal Neonatal Med 2014; 19:105–111.

Auteurs

Laura Sillers (L)

Division of Neonatal-Perinatal Medicine, Department of Pediatrics.

Stamatia Alexiou (S)

Division of Pulmonary Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Erik A Jensen (EA)

Division of Neonatal-Perinatal Medicine, Department of Pediatrics.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH